Medical Information Resource Library

Svintozelskiy et al 2026 Nicotinic Acetylcholine Receptor Modulation Distinguishes Clinical Benefits of Galantamine in AD Manuscript A Proposed Study Design Benzgalantamine Therapy on Sleep Quality and Behavioral and Psychological Symptoms in AD Poster Assessing Neuropsychiatric Symptoms Measured by NPI and CMAI A Literature-Based Practical Comparison for Clinicians Poster BEACON Study - Benzgalantamine Effectiveness And Cognition in Nursing Homes - Mixed-Methods Real-World Evidence Initiative Poster BEACON Study - Effects of Benzgalantamine Use on Cognition in LTC Residents in AD Poster BEACON Study - GI Tolerability of Benzgalantamine in LTC Residents with AD Poster BEACON Study - Real-World AChEI Treatment Patterns and Transition to Benzgalantamine in LTC Residents with AD Poster BEACON Study - Real-World Effects of Benzgalantamine on ADLs in LTC Residents with AD Poster BEACON Study - Real-World Effects of Benzgalantamine on NPS in LTC Residents with AD Poster BEACON Study - Real-World Effects of Benzgalantamine on Psychotropic Medication Utilization in LTC Residents with AD Poster BEACON Study - Real-World Effects of Benzgalantamine on Sleep-Related Outcomes in LTC Residents with AD Poster BEACON Study - Real-World Outcomes of Benzgalantamine Therapy in LTC Residents with AD Previously Treated with Donepezil Poster Bioequivalence of ZUNVEYL to Galantamine Hydrobromide Extended-Release Demonstrated Under Steady State Conditions Poster Bioequivalence of ZUNVEYL to Galantamine Hydrobromide Immediate-Release Demonstrated Under Fed and Fasting Conditions Poster Dose Proportionality of ZUNVEYL Over a Dosage Range of Five to Fifteen Milligrams Demonstrated Under Fasting Conditions Poster Literature Review Acetylcholinesterase Inhibitors and Effects on Mortality in ADRD Poster Literature Review Acetylcholinesterase Inhibitors and Effects on Sleep in AD Poster Literature Review AChEI Persistence and Value of Sustained Therapy in ADRD Poster Literature Review AChEIs and Psychotropic Use in AD and ADRD Poster Literature Review AChEIs Effects on Behaviors in AD Poster Literature Review AChEIs Support CMS Long-Term Care Psychotropic Medication Quality Measures Poster Literature Review Clinical Benefits of Galantamine and Benzgalantamine via Nicotinic Modulation in AD Poster Literature Review Evidence-Based Methodologies for Switching Between AChEIs in AD Poster Literature Review Impact of AChEIs on Caregiver Burden in AD Poster Impact of ZUNVEYL on Agitation Medical Letter Impact of ZUNVEYL on Behavioral Symptoms in AD (1) Medical Letter Impact of ZUNVEYL on Behavioral Symptoms in AD (2) Medical Letter ZUNVEYL and AChEI Switching Medical Letter ZUNVEYL and AChEIs Comparative Efficacy & Safety Medical Letter ZUNVEYL and AChEIs Effects on Sleep in AD Medical Letter ZUNVEYL and AChEIs in AD Mechanisms for GI Side Effects Medical Letter ZUNVEYL and BEACON Study (1) Medical Letter ZUNVEYL and CONVERGE Study Medical Letter ZUNVEYL and Galantamine Three Pivotal Phase III Clinical Trials Medical Letter ZUNVEYL and Long-Term Treatment of Galantamine in AD Medical Letter ZUNVEYL and Safety and Efficacy in Severe AD Medical Letter ZUNVEYL and the 505b2 Regulatory Pathway Medical Letter ZUNVEYL Bioequivalence Clinical Studies Medical Letter ZUNVEYL Components of the Drug Product Medical Letter ZUNVEYL Dosing and Administration Medical Letter ZUNVEYL Drug Product Formulation Advantages Medical Letter ZUNVEYL Mechanism of Action Medical Letter ZUNVEYL Metabolism Pharmacogenomics DDIs Medical Letter ZUNVEYL Whole Tablet Administration Medical Letter